Merck (MRK) Reports WELIREG Phase 3 LITESPARK-005 Trial Met Primary Endpoint streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
First positive Phase 3 results for WELIREG from LITESPARK-005 showed statistically significant improvements in PFS versus everolimus in these patientsRAHWAY, N.J. (BUSINESS WIRE) $MRK #MRK Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from LITESPARK-005,.
Railroad industry news about: American Public Transportation Association, APTA Hall of Fame, 2023 APTA Awards, New Jersey Transit, Bay Area Rapid Transit (BART), MTA Metro-North Railroad, Michael Allegra, Utah Transit Authority, Paul J. Ballard, Julie Cunningham, Sharon Greene, , Phillip A. Washington
. From the editors of Progressive Railroading Magazine